Trial intelligence / Profile preview

Sertraline for Dual Diagnosis PTSD and Alcohol Dependence

NCT02504931Phase 4Completed

Sponsor
UT Health San Antonio
Start
Apr 2011
Primary completion
Aug 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in post-traumatic stress disorder (PTSD) and alcohol use disorder (AUD) comparing Sertraline with Placebo (2 arms). Primary endpoint: Percent Heavy Drinking Days at 12 weeks. Started Apr 2011; status: completed.

02

Drugs

sertraline
03

Conditions

post-traumatic stress disorder (PTSD)alcohol use disorder (AUD)

Beyond the preview

Go deeper on NCT02504931.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02504931.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call